Singapore markets closed

Roche Holding AG (RHHVF)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
264.18+5.59 (+2.16%)
At close: 03:55PM EST

Roche Holding AG

Grenzacherstrasse 124
Basel 4058
Switzerland
41 61 688 11 11
https://www.roche.com

Sector(s)Healthcare
IndustryDrug Manufacturers - General
Full-time employees103,605

Key executives

NameTitlePayExercisedYear born
Dr. Severin Schwan Ph.D.Executive Chairman8.53MN/A1967
Dr. Thomas SchineckerChief Executive Officer4.4MN/A1975
Dr. Alan HippeChief Financial & Information Officer4.67MN/A1967
Dr. Bruno EschliHead of Investor RelationsN/AN/AN/A
Ms. Claudia BockstiegelGeneral CounselN/AN/A1964
Ms. Pascale SchmidtChief Compliance OfficerN/AN/A1973
Ms. Barbara SchadlerHead of Group CommunicationsN/AN/A1962
Ms. Cristina A. WilburChief People Officer3.32MN/A1967
Dr. Nicolas DunantHead of Group Media RelationsN/AN/AN/A
Mr. Boris L. ZaitraHead of Group Business Development and M&AN/AN/A1972
Amounts are as of 31 December 2022, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and Oceania. The company offers pharmaceutical products in the therapeutic areas of anemia, blood and solid tumors, dermatology, hemophilia, inflammatory and autoimmune, neurological disorders, ophthalmology, respiratory disorders, and transplantation. It is also developing products for various therapeutic areas. In addition, it offers in vitro tests for the diagnosis of various diseases, such as cancer, diabetes, Covid-19, hepatitis, human papillomavirus, and other diseases; diagnostic instruments; and digital health solutions. Roche Holding AG was founded in 1896 and is based in Basel, Switzerland.

Corporate governance

Roche Holding AG’s ISS governance QualityScore as of 1 February 2024 is 7. The pillar scores are Audit: 8; Board: 6; Shareholder rights: 6; Compensation: 7.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.